FemBloc® Permanent Contraception - Confirmation Feasibility Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 27, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

April 30, 2027

Conditions
Contraception
Interventions
DEVICE

FemBloc

Treatment with FemBloc for women who desire permanent birth control (female sterilization)

Trial Locations (6)

31909

Midtown OB GYN North, Columbus

44122

University Hospitals - Cleveland Medical Center, Beachwood

46825

Women's Health Advantage, Fort Wayne

48604

Saginaw Valley Medical Research Group, Saginaw

85032

Precision Trials AZ, LLC, Phoenix

85224

New Horizons Clinical Trials, Chandler

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Femasys Inc.

INDUSTRY

NCT04273594 - FemBloc® Permanent Contraception - Confirmation Feasibility Trial | Biotech Hunter | Biotech Hunter